Technical Analysis for NVIV - InVivo Therapeutics Holdings Corp.

Grade Last Price % Change Price Change
grade C 1.69 1.81% 0.03
NVIV closed up 1.81 percent on Friday, March 22, 2019, on 62 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Mar 25

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical NVIV trend table...

Date Alert Name Type % Chg
Mar 22 180 Bullish Setup Bullish Swing Setup 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Stochastic Reached Overbought Strength 0.00%
Mar 22 Outside Day Range Expansion 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 21 Narrow Range Bar Range Contraction 1.81%
Mar 21 NR7 Range Contraction 1.81%
Mar 21 Inside Day Range Contraction 1.81%
Mar 19 Crossed Above 50 DMA Bullish 2.42%
Mar 19 Pocket Pivot Bullish Swing Setup 2.42%

Older signals for NVIV ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Invivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injury (SCI). The company is developing a Neuro-Spinal Scaffold, an investigational bioresorbable polymer scaffold for the implantation at the site of injury within a spinal cord contusion; and biocompatible Neuro-Spinal Scaffold Plus Stem Cells to treat chronic SCI. Its proprietary technologies incorporate intellectual property licensed under exclusive, worldwide license from Boston Children's Hospital and the Massachusetts Institute of Technology, as well as intellectual property that has been developed internally in collaboration with advisors and partners. The company was founded in 2005 and is based in Cambridge, Massachusetts.
Biotechnology Organ Systems Stem Cells Injury Nervous System Biomaterials Injuries Medical Emergencies Spinal Cord Injury Neurotrauma
Is NVIV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.5
52 Week Low 1.34
Average Volume 63,002
200-Day Moving Average 2.0638
50-Day Moving Average 1.5393
20-Day Moving Average 1.5484
10-Day Moving Average 1.6291
Average True Range 0.0962
ADX 20.23
+DI 22.4124
-DI 15.8717
Chandelier Exit (Long, 3 ATRs ) 1.447
Chandelier Exit (Short, 3 ATRs ) 1.6686
Upper Bollinger Band 1.7405
Lower Bollinger Band 1.3563
Percent B (%b) 0.87
BandWidth 24.81271
MACD Line 0.0419
MACD Signal Line 0.0231
MACD Histogram 0.0188
Fundamentals Value
Market Cap 54.39 Million
Num Shares 32.2 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -2.22
Price-to-Sales 0.00
Price-to-Book 2.29
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.83
Resistance 3 (R3) 1.81 1.76 1.80
Resistance 2 (R2) 1.76 1.72 1.76 1.79
Resistance 1 (R1) 1.72 1.70 1.74 1.74 1.79
Pivot Point 1.67 1.67 1.68 1.67 1.67
Support 1 (S1) 1.63 1.63 1.65 1.65 1.59
Support 2 (S2) 1.58 1.61 1.58 1.59
Support 3 (S3) 1.54 1.58 1.58
Support 4 (S4) 1.56